Viscientbiosciences
1 known investors
Viscient develops 3D human tissue models for drug development, replacing animal models in preclinical and clinical testing. The company has created a liver disease model and advanced drug candidates toward clinical trials.
BiotechDeep TechDigital Health
Investors Β· 1
Frequently asked questions
- What does Viscientbiosciences do?
- Viscient develops 3D human tissue models for drug development, replacing animal models in preclinical and clinical testing. The company has created a liver disease model and advanced drug candidates toward clinical trials.
- Who are Viscientbiosciences's investors?
- Viscientbiosciences's investors include Thynk Capital.